ImmunoGenesis Announces Two Publications Highlighting the Potential of IMGS-203, a Novel Stimulator of Interferon Genes (STING) Agonist, to Overcome Tumor Immune Resistance and Enhance Antitumor…

The Quick Take
HOUSTON, Nov. 5, 2026 /PRNewswire/ -- ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced two publications providing new nonclinical evidence and scientific insights into the ability of its novel stimulator of interferon...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
Latest $55,000 contribution extends the Tucson company's multi-year commitment to local students TUCSON, Ariz., Nov. 5, 2026 /PRNewswire/ -- Arizona Pest…
Business
CPSC and ASTM International Announce Stronger Safety Standard for Above-Ground Pool Ladders
New Child-Resistance Requirements Advance CPSC's Drowning Prevention Priorities WASHINGTON, Nov. 5, 2026 /PRNewswire/ -- The U.S. Consumer Product Safety…
Business
Varda's W-8 Capsule Returns Safely from Orbit as Three Vehicles Operate in Space
Reentry marks the company's first multi-vehicle operation, with W-7 and W-9 still on orbit. EL SEGUNDO, Calif., Nov. 5, 2026 /PRNewswire/ -- Varda Space…
Business
Centric Consulting Earns Widespread Recognition For Excellence In 2026
Eight honors recognize the firm's consulting expertise, workplace culture, technology leadership and creative achievements DAYTON, Ohio, Nov. 5, 2026…
